AMPH vs EW · P/E 12, rev $732.0M vs P/E 47, rev $1.39B
Amphastar P (AMPH) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AMPH and EW stock pages for the full models.
Not investment advice.